Chronic Chlamydia pneumoniae Infections

  • P. Saikku


Chronic infections are the most important chlamydial infections. Moreover, with the rising average lifetime, the incidence and importance of chronic infections with late sequelae tend to rise. Chlamydia trachomatis infections may take tens of years for blindness to develop in trachoma; grave symptoms of lymphogranuloma venereum (LGV) are seen after years of progression, and it takes years to develop complications of chronic silent pelvic inflammatory disease (PID), such as ectopic pregnancy and infertility.


Acute Myocardial Infarction Chronic Fatigue Syndrome Chlamydial Infection Reactive Arthritis Lymphogranuloma Venereum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schachter J, Moncada J, Dawson CR, Sheppard J, Courtright P, Said ME, Zaki S, Hafez SF, Lorincz A (1988) Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis 158: 1347–1352PubMedCrossRefGoogle Scholar
  2. 2.
    Gérard HC, Branigan PJ, Schumacher HR, Hudson AP (1998) Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter’s syndrome are viable but show aberrant gene expression. J Rheumatol 25: 734–742PubMedGoogle Scholar
  3. 3.
    Wang S-P, Grayston JT (1986) Microimmunofluorescence serological studies with the TWAR organism. In: Oriel JD, Ridgway G, Schachter J, Taylor-Robinson D (eds) Chlamydial infections. Cambridge University Press, Cambridge, pp 329–332Google Scholar
  4. 4.
    Wang S-P, Grayston JT (1982) Micro-immunofluorescence antibody responses in Chlamydia trachomatis infection, a review. In: Mårdh PA, Holmes KK, Oriel JD, Piot P, Schachter J (eds) Chlamydial infections. Elsevier, Amsterdam, pp 301–316Google Scholar
  5. 5.
    Sarov I, Sarov B, Hanuka N, Glasner M, Kaneti J (1986) The significance of serum specific IgA antibodies in diagnosis of active Chlamydia trachomatis infections. In: Oriel D, Ridgway G, Schacter J, Taylor-Robinson D, Ward M (eds) Chlamydial infections. Cambridge University Press, Cambridge, pp 566–569Google Scholar
  6. 6.
    von Hertzen L, Leinonen M, Surcel HM, Karjalainen J, Saikku P (1995) Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immunol 2: 454–457Google Scholar
  7. 7.
    Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME (1998) Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 11: 345–349PubMedCrossRefGoogle Scholar
  8. 8.
    Saikku P, Wang S-P, Kleemola M, Brander E, Rusanen E, Grayston JT (1985) An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 151: 832–839PubMedCrossRefGoogle Scholar
  9. 9.
    Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, Huttunen J, Valtonen V (1988) Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii: 983–985CrossRefGoogle Scholar
  10. 10.
    Grayston JT, Golubjatnikov R, Hagiwara T, Hahn DL, Leinonen M, Persson K, Saikku P, Treharne J, Wang S-P (1993) Serologic tests for Chlamydia pneumoniae. Pediatr Infect Dis J 11: 790–791Google Scholar
  11. 11.
    Campbell LA, Kuo C-C, Wang S-P, Grayston JT (1990) Serological response to Chlamydia pneumoniae infection. J Clin Microbiol 28: 1261–1264PubMedGoogle Scholar
  12. 12.
    Puolakkainen M, Kuo C-C, Shor A, Wang S-P, Grayston JT, Campbell LA (1993) Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 31: 2212–2214PubMedGoogle Scholar
  13. 13.
    Puolakkainen M, Campbell LA, Kuo C-C, Leinonen M, Grönhagen-Riska C, Saikku P (1996) Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect 33: 199–205PubMedCrossRefGoogle Scholar
  14. 14.
    Maass M, Gieffers J (1997) Cardiovascular disease risk from prior Chlamydia pnemoniae infection can be related to certain antigens recognized in the immunoblot profile. J Infect 35: 171–176PubMedCrossRefGoogle Scholar
  15. 15.
    Leinonen M, Linnanmäki E, Mattila K, Nieminen MS, Valtonen V, Leirisalo-Repo M, Saikku P (1990) Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 9: 67–73PubMedCrossRefGoogle Scholar
  16. 16.
    Linnanmäki E, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Valtonen V, Saikku P (1993) Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation 87: 1130–1134PubMedGoogle Scholar
  17. 17.
    Kol A, Sukhova GK, Lichtman AH, Libby P (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-a and matrix metalloproteinase expression. Circulation 98: 300–307PubMedGoogle Scholar
  18. 18.
    Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167: 841–849PubMedCrossRefGoogle Scholar
  19. 19.
    von Hertzen L, Alakärppä H, Koskinen R, Liippo K, Surcel H-M, Leinonen M, Saikku P (1997) Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 118: 155–164CrossRefGoogle Scholar
  20. 20.
    Boman J, Söderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waldenström A, Wadell G (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178: 274–277PubMedCrossRefGoogle Scholar
  21. 21.
    Shor A, Kuo C-C, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S African Med J 82: 158–160Google Scholar
  22. 22.
    Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P (1994) Importance of smoking for Chlamydia pneumoniae infection. Int J Epidemiol 23: 1315–1321PubMedCrossRefGoogle Scholar
  23. 23.
    Verkooyen RP, Vanlent NA, Joulandan SAM, Snijder RJ, Vandenbosch JM, Vanhelden HP, Verbrugh HA (1997) Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA. J Med Microbiol 46: 959–964PubMedCrossRefGoogle Scholar
  24. 24.
    Blasi F, Legnani D, Negretto G, Caratozzolo O, Magliano E, Chiodo F, Pozzoli R, Fasoli A (1992) Incidence and prevalence of Chlamydia pneumoniae infection in COAD patients. J Infect 25[Suppl 1]: 125–126CrossRefGoogle Scholar
  25. 25.
    Blasi F, Legnani D, Lombardo VM, Negretto GG, Magliano E, Pozzoli R, Chiodo F, Fasoli A, Allegra L (1993) Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 6: 19–22PubMedGoogle Scholar
  26. 26.
    von Hertzen L, Isoaho R, Leinonen M, Koskinen R, Laippala P, Töyrylä M, Kivelä SL, Saikku P (1996) Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 25: 658–664CrossRefGoogle Scholar
  27. 27.
    Hahn DL, Dodge RW, Golubjatnikov R (1991) Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266: 225–230PubMedCrossRefGoogle Scholar
  28. 28.
    Hahn DL, Golubjatnikov R (1994) Adult onset asthma and atypical infection: a case series. J Fam Pract 38: 589–595PubMedGoogle Scholar
  29. 29.
    Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag M (1995) Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 172: 265–267PubMedCrossRefGoogle Scholar
  30. 30.
    Grönhagen-Riska C, Saikku P, Riska H, Fröseth B, Grayston JT (1988) Antibodies to TWAR — a novel type of Chlamydia — in sarcoidosis. In: Grassi C (ed) Sarcoidosis and other granulomatous disorders. Elsevier, Amsterdam, pp 297–301Google Scholar
  31. 31.
    Campbell JF, Barnes RC, Kozarsky PE, Spika JS (1991) Culture-confirmed pneumonia due to Chlamydia pneumoniae. J Infect Dis 164: 411–413PubMedCrossRefGoogle Scholar
  32. 32.
    Black CM, Perez R (1990) Chlamydia pneumoniae multiplies within human alveolar macrophages. In: Abstracts of the 90th Annual Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, DC, p 80Google Scholar
  33. 33.
    Blasi F, Rizzato G, Gambacorta M, Cosentini R, Raccanelli R, Tarsia P, Arosio C, Savini E, Cantoni C, Fagetti L, Allegra L (1997) Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens. Eur Respir J 10: 2609–2611PubMedCrossRefGoogle Scholar
  34. 34.
    Jackson LA, Campbell LA, Schmidt RA, Kuo C-C, Cappuccio AL, Lee MJ, Grayston JT (1997) Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma — evaluation of the innocent bystander hypothesis. Am J Pathol 150: 1785–1790PubMedGoogle Scholar
  35. 35.
    Laurila AL, Anttila T, Läärä E, Bloigu A, Virtamo J, Leinonen M, Albanes D, Saikku P (1997) Serologic evidence of an association of chronic Chlamydia pneumoniae infection with lung cancer. Int J Cancer 74: 31–34PubMedCrossRefGoogle Scholar
  36. 36.
    Falck G, Heyman L, Gnarpe J, Gnarpe H (1995) Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 27: 179–182PubMedCrossRefGoogle Scholar
  37. 37.
    Falck G, Gnarpe J, Gnarpe H (1996) Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis 28: 271–273PubMedCrossRefGoogle Scholar
  38. 38.
    Goo YA, Hori MK, Voorhies JH Jr, Kuo C-C, Wang S-P, Campbell LA (1995) Failure to detect Chlamydia pneumoniae in ear fluids from children with otitis media. Pediatr Infect Dis J 11: 100–101Google Scholar
  39. 39.
    Ogawa H, Hashigucci K, Kazuyama Y (1992) Recovery of C. pneumoniae in six patients with otitis media with effusion. J Laryngol Otol 106: 490–492PubMedGoogle Scholar
  40. 40.
    Kousa M, Saikku P, Kanerva L (1980) Erythema nodosum in chlamydial infections. Acta Dermatovener (Stockholm) 60: 319–322Google Scholar
  41. 41.
    Sarner M, Wilson RJ (1965) Erythema nodosum and psittacosis: report of five cases. BMJ 2: 1469–1470PubMedCrossRefGoogle Scholar
  42. 42.
    Erntell M, Ljunggren K, Gadd T, Persson K (1989) Erythema nodosum — a manifestation of Chlamydia pneumoniae (strain TWAR) infection. Scand J Infect Dis 21: 693–696PubMedCrossRefGoogle Scholar
  43. 43.
    Sundelöf B, Gnarpe H, Gnarpe J (1993) An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum. Scand J Infect Dis 25: 259–261PubMedCrossRefGoogle Scholar
  44. 44.
    Saario R, Toivanen A (1994) Chlamydia pneumoniae as a cause of reactive arthritis. Br J Rheumatol 33: 1112 (letter)Google Scholar
  45. 45.
    Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, Sieper J (1994) C. pneumoniae: a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 53: 100–105PubMedCrossRefGoogle Scholar
  46. 46.
    Moling O, Picoretti S, Rielli M, Rimenti G, Vedovelli C, Pristera R, Mian P (1996) Chlamydia pneumoniae — reactive arthritis and persistent infection. Br J Rheumatol 35: 189–190CrossRefGoogle Scholar
  47. 47.
    Braun J, Tuszewski M, Eggens U, Mertz A, Schauer-Petrowskaja C, Döring E, Laitko S, Distler A, Sieper J, Ehlers S (1997) Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondylarthropathies and other arthritides. J Rheumatol 24: 1092–1100PubMedGoogle Scholar
  48. 48.
    Lauhio A, Leirisalo-Repo M, Lähdevirta J, Saikku P, Repo H (1991) Double-blind, placebo-controlled study of three-month lymecycline course in reactive arthritis with special reference to Chlamydia arthritis. Arthritis Rheum 34: 6–14PubMedCrossRefGoogle Scholar
  49. 49.
    Komaroff AL, Wang S-P, Lee J, Grayston JT (1992) No association of chronic Chlamydia pneumoniae infection with chronic fatigue syndrome. J Infect Dis 165: 182 (letter)CrossRefGoogle Scholar
  50. 50.
    Anttila TI, Lehtinen T, Leinonen M, Bloigu A, Koskela P, Lehtinen M, Saikku P (1998) Serological evidence of an association between chlamydial infections and malignant lymphomas. Br J Haematol 103: 150–156PubMedCrossRefGoogle Scholar
  51. 51.
    May J (1943) La intradermoreacción de Frei en las arteropatias. Rev Argent Dermatosifil 27: 581–582Google Scholar
  52. 52.
    Quiroga, Ambrosetti FE (1943) La reacción de Frei en las endoarteritis obliterantes. Rev Argent Dermatosifil 27: 624–625Google Scholar
  53. 53.
    Coutts WE, Davila M (1945) Lymphogranuloma venereum as a possible cause of arterio-sclerosis and other arterial conditions. J Trop Med Hyg 48: 46–51Google Scholar
  54. 54.
    Kuo C-C, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang S-P, Grayston JT (1997) Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 26: 29–31PubMedCrossRefGoogle Scholar
  55. 55.
    Väätäinen NJ, Alila MH, Kärkkäinen AT (1993) Chlamydia pneumoniae as a trigger of IgA-associated small dermal vessel leukocytoclastic vasculitis (adult Henoch-Schönlein purpura). Eur J Dermatol 7: 610Google Scholar
  56. 56.
    Ljungström L, Franzén C, Schlaug M, Elowson S, Viidas U (1997) Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels. Scand J Infect Dis Suppl 104: 37–40PubMedGoogle Scholar
  57. 57.
    Sutton GC, Demakis JA, Anderson, Morrisey RA (1971) Serologic evidence of a sporadic outbreak in Illinois of infection by Chlamydia (psittacosis-LGV agent) in patients with primary myocardial disease and respiratory disease. Am Heart J 81: 597–607PubMedCrossRefGoogle Scholar
  58. 58.
    Black CM, Johnson JE, Farshy CE, Brown TM, Berdal BP (1991) Antigenic variation among strains of Chlamydia pneumoniae. J Clin Microbiol 29: 1312–1316PubMedGoogle Scholar
  59. 59.
    Wesslén L, Påhlson C, Lindquist O, Hjelm E, Gnarpe J, Larsson E, Baandrup U, Eriksson L, Fohlman J, Engstrand L, Linglöf T, Nyström-Rosander C, Gnarpe H, Magnius L, Rolf C, Friman G (1992) An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979–1992. Eur Heart J 17: 902–910CrossRefGoogle Scholar
  60. 60.
    Haagen E (1964) Miyagawanellen In: Viruskrankheiten des Menschen, Band I. Dietrich Steinkopff Verlag, Darmstadt, pp 807–1052CrossRefGoogle Scholar
  61. 61.
    Odeh M, Oliven A (1992) Chlamydial infections of the heart. Eur J Clin Microbiol Infect Dis 11: 885–893PubMedCrossRefGoogle Scholar
  62. 62.
    Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350: 430–436PubMedCrossRefGoogle Scholar
  63. 63.
    Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S (1998) Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 26: 719–734PubMedCrossRefGoogle Scholar
  64. 64.
    Thom DH, Wang S-P, Grayston JT, Siscovick DS, Stewart DK, Kronmal RA, Weiss NS (1991) Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arteriosclerosis Thromb 11: 547–551CrossRefGoogle Scholar
  65. 65.
    Miettinen H, Lehto S, Saikku P, Haffner SM, Rönnemaa T, Pyörälä K, Laakso M (1996) Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-dibetic subjects in Finland. Eur Heart J 17: 682–688PubMedCrossRefGoogle Scholar
  66. 66.
    Saikku P, Leinonen M, Tenkanen L, Ekman MR, Linnanmäki E, Manninen V, Mänttäri M, Frick MH, Huttunen JK (1992) Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 116: 273–278PubMedGoogle Scholar
  67. 67.
    Ossewaarde JM, Feskens EJM, De Vries A, Vallinga CE, Kromhout D (1998) Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 120: 93–99PubMedCrossRefGoogle Scholar
  68. 68.
    Davidson M, Kuo C-C, Middaugh JP, Campbell LA, Wang S-P, Newman WP, Finlay JC, Grayston JT (1998) Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 98: 628–633PubMedGoogle Scholar
  69. 69.
    Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour Ca, Camm AJ, Northfield TC (1995) Association of Helicobacter pylori an Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311: 711–714PubMedCrossRefGoogle Scholar
  70. 70.
    Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M (1993) Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 95: 499–504PubMedCrossRefGoogle Scholar
  71. 71.
    Thom DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Dailing JR (1992) Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268: 68–72PubMedCrossRefGoogle Scholar
  72. 72.
    Dahlén GH, Boman J, Birgander LS, Lindblom B (1995) Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114: 165–174PubMedCrossRefGoogle Scholar
  73. 73.
    Haidl S, Juul-Möller S, Israelsson B, Persson K (1992) Ischemic heart disease and antibodies to Chlamydia pneumoniae (TWAR). Proc Eur Soc Chlamydia Res 2: 174Google Scholar
  74. 74.
    Blasi F, Cosentini R, Raccanelli R, Massari FM, Arosio C, Tarsia P, Allegra L (1997) A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 112: 309–312PubMedCrossRefGoogle Scholar
  75. 75.
    Thomas GN, Scheel O, Koehler AP, Basset DCJ, Cheng AFB (1997) Respiratory chlamy— dial infections in a Hong Kong teaching hospital and association with coronary heart disease. Scand J Infect Dis Suppl 104: 30–33PubMedGoogle Scholar
  76. 76.
    Mazzoli S, Tofani N, Fantini A, Semplici F, Bandini F, Salvi A, Vergassola R (1998) Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J 135: 15–20PubMedCrossRefGoogle Scholar
  77. 77.
    Perdikaris G, Mentis A, Makris Th, Pourmaras G, Dafnou A, Xatzizaharias A, Votieas V, Giamarellou H (1997) Serologic response to Chlamydia pneumoniae (Cpn) in Greek adults with chronic coronary heart disease (CCHD) and acute myocardial infarction (AMI) (preliminary report). Clin Infect Dis 25: 369Google Scholar
  78. 78.
    Diedrichs H, Schneider CA, Scharkus S, Pfister H, Erdmann E (1997) Prävalenz von Chlamydien-Antikörpern bei Patienten mit koronarer Herzerkrankung. Herz Kreislauf 29: 304–307Google Scholar
  79. 79.
    Kark J, Leinonen M, Paltiel O, Saikku P (1997) Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 26: 730–738PubMedCrossRefGoogle Scholar
  80. 80.
    Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC (1995) Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 30: 121–128PubMedCrossRefGoogle Scholar
  81. 81.
    Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani E, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schacter J (1996) Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173: 957–962PubMedCrossRefGoogle Scholar
  82. 82.
    Wimmer M, Sandmann-Strupp R, Saikku P, Haberl RL (1996) Association of chlamy — dial infection with cerebrovascular diseases. Stroke 27: 207–210CrossRefGoogle Scholar
  83. 83.
    Aceti A, Mazzacurati G, Amendolea MA, Fennica A, Zechini B, Trappolini M, Puletti M (1996) H pylori and C. pneumoniae infections may account for most acute coronary syndromes. BMJ 313: 428–429 (letter)PubMedCrossRefGoogle Scholar
  84. 84.
    Cook PJ, Honeybourne D, Lip GYH, Beevers DG, Wise R (1995) Chlamydia pneumoniae and acute arterial thrombotic disease. Circulation 92: 3148 (letter)PubMedGoogle Scholar
  85. 85.
    Gieffers J, Maass M (1995) Serological response to Chlamydia pneumoniae in coronary heart disease. In: Abstracts of the 7th ECCMID, Vienna, no 495, p 95Google Scholar
  86. 86.
    Godzik KL, O’Brien ER, Wang SK, Kuo C-C (1995) In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33: 2411–2414PubMedGoogle Scholar
  87. 87.
    Ramirez JA, (1997) Chlamydia pneumoniae/atherosclerosis Study Group Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125: 97–98Google Scholar
  88. 88.
    Maass M, Bartels C, Engel PM, Mamat U, Sievers HH (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31: 827–832PubMedCrossRefGoogle Scholar
  89. 89.
    Mosorin M, Surcel HM, Laurila A, Saikku P, Juvonen T (1998) Chlamydia pneumoniaereactive T lymphocytes in atherosclerotic plaque of carotid artery. In: Stephens RS et al (eds) Chlamydial infections. International Chlamydia Symposium, San Francisco, pp 423-425Google Scholar
  90. 90.
    Campbell LA, O’Brien ER, Cappuccio AL, Kuo C-C, Wang S-P, Stewart D, Patton DL, Cummings PK, Grayston JT (1995) Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172: 585–588PubMedCrossRefGoogle Scholar
  91. 91.
    Cook PJ, Honeybourne D, Lip GYH, Beevers DG, Wise R, Davies P (1998) Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia — the West Birmingham stroke project. Stroke 29: 404–410PubMedCrossRefGoogle Scholar
  92. 92.
    Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H (1998) Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29: 773–778PubMedCrossRefGoogle Scholar
  93. 93.
    Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D (1996) Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 49: 102–106PubMedCrossRefGoogle Scholar
  94. 94.
    Juvonen J, Laurila A, Alakärppä H, Leinonen M, Surcel HM, Juvonen T, Kairaluoma M, Saikku P (1997) Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 25: 499–505PubMedCrossRefGoogle Scholar
  95. 95.
    Juvonen J, Laurila A, Juvonen T, Alakärppä H, Surcel HM, Lounatmaa K, Kuusisto J, Saikku P (1997) Detection of Chlamydia pneumoniae in human non-rheumatic stenotic aortic valves. J Am Coll Cardiol 29: 1054–1059PubMedCrossRefGoogle Scholar
  96. 96.
    Taylor-Robinson D, Ong G, Thomas BJ, Rose ML, Yacoub MH (1998) Chlamydia pneumoniae in vascular tissues from heart-transplant donors (research letter). Lancet 351: 1255PubMedCrossRefGoogle Scholar
  97. 97.
    Juvonen J, Juvonen T, Laurila A, Kuusisto J, Bodian CA, Alarakkola E, Särkioja T, Kairaluoma MI, Saikku P (1997) Can degenerative tricuspid aoric valve stenosis be caused by a persistent Chlamydia pneumoniae infection? A study of 46 cadavers. Ann Intern Med 128: 741–744Google Scholar
  98. 98.
    Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ (1995) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96: 404–407Google Scholar
  99. 99.
    Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, Roxis Study Group (1997) Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350: 404–407PubMedCrossRefGoogle Scholar
  100. 100.
    Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J (1997) Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35: 48–52PubMedGoogle Scholar
  101. 101.
    Laitinen K, Laurila A, Pyhälä L, Leinonen M, Saikku P (1997) Chlamydia pneumoniaeinfection induces inflammatory changes in the aorta of rabbits. Infect Immun 65: 4832–4835PubMedGoogle Scholar
  102. 102.
    Muhlestein JB, Anderson JL, Hammond EH, Zhao LP, Trehan S, Schwobe EP, Carlquist JF (1998) Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97: 633–636PubMedGoogle Scholar
  103. 103.
    Freidank HM, Billing H (1997) Influence of iron restriction on the growth of Chlamydia pneumoniae TWAR and Chlamydia trachomatis. Clin Microbiol Infect 3[Suppl 2]: 193Google Scholar
  104. 104.
    von Hertzen L, Surcel HM, Kaprio J, Koskenvuo M, Leinonen M, Saikku P (1998) Effect of smoking on humoral and cell-mediated immune response to Chlamydia pneumoniae in twins. J Med Microbiol 47: 441–446CrossRefGoogle Scholar
  105. 105.
    Kalayoglu MV, Byrne GI (1998) Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 177: 725–729PubMedCrossRefGoogle Scholar
  106. 106.
    Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC (1996) C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312: 1061–1065PubMedCrossRefGoogle Scholar
  107. 107.
    Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M (1996) Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 21: 215–221PubMedCrossRefGoogle Scholar
  108. 108.
    Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P (1997) Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 17: 2910–2913PubMedCrossRefGoogle Scholar
  109. 109.
    Cook PJ, Lip GYH, Davies P, Beevers DG, Wise R, Honeybourne D (1998) Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 31: 589–594PubMedGoogle Scholar
  110. 110.
    Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H (1998) Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351: 1467–1471PubMedCrossRefGoogle Scholar
  111. 111.
    Valkonen K, Saikku P (1996) Proteinase associated with Chlamydia pneumoniae. In: Proceedings of the 3rd Meeting of the European Society for Chlamydia Research, Vienna, 11–14 September, 1996. Esculapio, BolognaGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • P. Saikku

There are no affiliations available

Personalised recommendations